Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study.
Torben Plesner
Consultant or Advisory Role - Genmab
Honoraria - Genmab
Expert Testimony - Genmab
Henk M Lokhorst
Consultant or Advisory Role - Genmab
Research Funding - Genmab
Peter Gimsing
No relevant relationships to disclose
Hareth Nahi
No relevant relationships to disclose
Steen Lisby
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Paul Gerard Guy Richardson
Consultant or Advisory Role - Genmab